144 related articles for article (PubMed ID: 31432325)
1. Mcl-1 Inhibitor Induces Cells Death in BRAF-Mutant Amelanotic Melanoma Trough GSH Depletion, DNA Damage and Cell Cycle Changes.
Respondek M; Beberok A; Rzepka Z; Rok J; Wrześniok D
Pathol Oncol Res; 2020 Jul; 26(3):1465-1474. PubMed ID: 31432325
[TBL] [Abstract][Full Text] [Related]
2. MIM1 induces COLO829 melanoma cell death through mitochondrial membrane breakdown, GSH depletion, and DNA damage.
Respondek M; Beberok A; Rzepka Z; Rok J; Wrześniok D
Fundam Clin Pharmacol; 2020 Feb; 34(1):20-31. PubMed ID: 31410885
[TBL] [Abstract][Full Text] [Related]
3. MIM1, the Mcl-1 - specific BH3 mimetic induces apoptosis in human U87MG glioblastoma cells.
Respondek M; Beberok A; Rok J; Rzepka Z; Wrześniok D; Buszman E
Toxicol In Vitro; 2018 Dec; 53():126-135. PubMed ID: 30134184
[TBL] [Abstract][Full Text] [Related]
4. The role of MITF and Mcl-1 proteins in the antiproliferative and proapoptotic effect of ciprofloxacin in amelanotic melanoma cells: In silico and in vitro study.
Beberok A; Rok J; Rzepka Z; Marciniec K; Boryczka S; Wrześniok D
Toxicol In Vitro; 2020 Aug; 66():104884. PubMed ID: 32437906
[TBL] [Abstract][Full Text] [Related]
5. The role of UVA radiation in ketoprofen-mediated BRAF-mutant amelanotic melanoma cells death - A study at the cellular and molecular level.
Banach K; Kowalska J; Rzepka Z; Beberok A; Rok J; Wrześniok D
Toxicol In Vitro; 2021 Apr; 72():105108. PubMed ID: 33545343
[TBL] [Abstract][Full Text] [Related]
6. Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.
Singh S; Davis R; Alamanda V; Pireddu R; Pernazza D; Sebti S; Lawrence N; Chellappan S
Mol Cancer Ther; 2010 Dec; 9(12):3330-41. PubMed ID: 21139044
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Effect of Vanicosides A and B from Reynoutria sachalinensis Against Melanotic and Amelanotic Melanoma Cell Lines and in silico Evaluation for Inhibition of BRAFV600E and MEK1.
Nawrot-Hadzik I; Choromańska A; Abel R; Preissner R; Saczko J; Matkowski A; Hadzik J
Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32610527
[TBL] [Abstract][Full Text] [Related]
8. UVA Radiation Enhances Lomefloxacin-Mediated Cytotoxic, Growth-Inhibitory and Pro-Apoptotic Effect in Human Melanoma Cells through Excessive Reactive Oxygen Species Generation.
Beberok A; Rzepka Z; Rok J; Banach K; Wrześniok D
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255659
[TBL] [Abstract][Full Text] [Related]
9. Proteasome inhibitors against amelanotic melanoma.
Sidor-Kaczmarek J; Cichorek M; Spodnik JH; Wójcik S; Moryś J
Cell Biol Toxicol; 2017 Dec; 33(6):557-573. PubMed ID: 28281027
[TBL] [Abstract][Full Text] [Related]
10. The Novel ATP-Competitive MEK/Aurora Kinase Inhibitor BI-847325 Overcomes Acquired BRAF Inhibitor Resistance through Suppression of Mcl-1 and MEK Expression.
Phadke MS; Sini P; Smalley KS
Mol Cancer Ther; 2015 Jun; 14(6):1354-64. PubMed ID: 25873592
[TBL] [Abstract][Full Text] [Related]
11. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Mcl-1 confers resistance to BRAFV600E inhibitors alone and in combination with MEK1/2 inhibitors in melanoma.
Fofaria NM; Frederick DT; Sullivan RJ; Flaherty KT; Srivastava SK
Oncotarget; 2015 Dec; 6(38):40535-56. PubMed ID: 26497853
[TBL] [Abstract][Full Text] [Related]
13. Moxifloxacin as an inducer of apoptosis in melanoma cells: A study at the cellular and molecular level.
Beberok A; Rzepka Z; Respondek M; Rok J; Stradowski M; Wrześniok D
Toxicol In Vitro; 2019 Mar; 55():75-92. PubMed ID: 30528372
[TBL] [Abstract][Full Text] [Related]
14. AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells.
Carpi S; Fogli S; Romanini A; Pellegrino M; Adinolfi B; Podestà A; Costa B; Da Pozzo E; Martini C; Breschi MC; Nieri P
Anticancer Drugs; 2015 Aug; 26(7):754-62. PubMed ID: 25974027
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with Ad-hTRAIL and DTIC or SAHA is associated with increased mitochondrial-mediated apoptosis in human melanoma cell lines.
Lillehammer T; Engesaeter BO; Prasmickaite L; Maelandsmo GM; Fodstad O; Engebraaten O
J Gene Med; 2007 Jun; 9(6):440-51. PubMed ID: 17410615
[TBL] [Abstract][Full Text] [Related]
16. Mcl-1 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells.
Sarif Z; Tolksdorf B; Fechner H; Eberle J
Mol Carcinog; 2020 Nov; 59(11):1256-1268. PubMed ID: 32885857
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells.
Vitiello M; Tuccoli A; D'Aurizio R; Sarti S; Giannecchini L; Lubrano S; Marranci A; Evangelista M; Peppicelli S; Ippolito C; Barravecchia I; Guzzolino E; Montagnani V; Gowen M; Mercoledi E; Mercatanti A; Comelli L; Gurrieri S; Wu LW; Ope O; Flaherty K; Boland GM; Hammond MR; Kwong L; Chiariello M; Stecca B; Zhang G; Salvetti A; Angeloni D; Pitto L; Calorini L; Chiorino G; Pellegrini M; Herlyn M; Osman I; Poliseno L
Oncotarget; 2017 Apr; 8(15):25395-25417. PubMed ID: 28445987
[TBL] [Abstract][Full Text] [Related]
18. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
[TBL] [Abstract][Full Text] [Related]
19. Effects of electrophotodynamic therapy in vitro on human melanoma cells--melanotic (MeWo) and amelanotic (C32).
Choromanska A; Kulbacka J; Rembialkowska N; Pilat J; Drag-Zalesinska M; Wysocka T; Garbiec A; Kotulska M; Saczko J
Melanoma Res; 2015 Jun; 25(3):210-24. PubMed ID: 25756554
[TBL] [Abstract][Full Text] [Related]
20. The Anticancer Potential of Doxycycline and Minocycline-A Comparative Study on Amelanotic Melanoma Cell Lines.
Rok J; Rzepka Z; Kowalska J; Banach K; Beberok A; Wrześniok D
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
